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Abstract
Lysine acetylation is a reversible post-translational modification (PTM) that has been de-
tected on thousands of proteins in nearly all cellular compartments. The role of this wide-
spread PTM has yet to be fully elucidated, but can impact protein localization, interactions,
activity, and stability. Here we present the first proteome-wide survey of lysine acetylation in
cortical astrocytes, a subtype of glia that is a component of the blood-brain barrier and a key
regulator of neuronal function and plasticity. We identified 529 lysine acetylation sites
across 304 proteins found in multiple cellular compartments that largely function in RNA
processing/transcription, metabolism, chromatin biology, and translation. Two hundred and
seventy-seven of the acetylated lysines we identified on 186 proteins have not been re-
ported previously in any other cell type. We also mapped an acetylome of astrocytes in-
fected with the brain parasite, Toxoplasma gondii. It has been shown that infection with T.
gondiimodulates host cell gene expression, including several lysine acetyltransferase
(KAT) and deacetylase (KDAC) genes, suggesting that the host acetylome may also be al-
tered during infection. In the T. gondii-infected astrocytes, we identified 34 proteins exhibit-
ing a level of acetylation>2-fold and 24 with a level of acetylation<2-fold relative to
uninfected astrocytes. Our study documents the first acetylome map for cortical astrocytes,
uncovers novel lysine acetylation sites, and demonstrates that T. gondii infection produces
an altered acetylome.
Introduction
Astrocytes constitute a major subset of glial cells that carry out a wide variety of critical opera-
tions in the mammalian brain. It is well-established that astrocytes play a supportive role for
neurons by providing metabolic support, releasing and taking up neurotransmitters, and
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maintaining extracellular ionic concentrations. Emerging studies suggest that in addition to the
long-established structural role astrocytes play in the maintenance of the blood-brain barrier
(BBB), astrocytes are key players in neuronal signaling, brain repair, and immune responses
[1]. In response to infection, astrocytes release cytokines and chemokines to modulate effector
cells. There is also evidence that infection can alter astrocyte function; for example, HIV-in-
fected astrocytes develop abnormal end-feet connections that lead to perturbations in the BBB
[2]. Other intracellular microbes capable of infecting astrocytes include Listeria monocytogenes
and Toxoplasma gondii [3–5], but how they may modulate astrocyte function has yet to
be defined.
T. gondii is an obligate, intracellular parasite belonging to the phylum Apicomplexa, which
also includes other notorious protozoan pathogens such as Plasmodium spp. (malaria) and
Cryptosporidium spp. (cryptosporidiosis). Up to a third of the world’s population is infected
with T. gondii, which can reactivate as life-threatening disease in immunocompromised indi-
viduals. In addition, T. gondii infection during pregnancy can cause congenital birth defects, in-
cluding blindness or hydrocephalus [6]. T. gondii is commonly transmitted to virtually any
warm-blooded vertebrate through oocysts expelled by its definitive host (felines) or bradyzoite-
containing tissue cysts residing in undercooked meat [7]. The tachyzoite stage of the parasite’s
life cycle is characterized by rapid proliferation (doubling time of 6–10 hours) in any nucleated
cell and can cause acute disease associated with tissue destruction. In immune competent
hosts, the tachyzoites are induced to differentiate into bradyzoites, which are believed to be
largely quiescent for the remainder of the host’s life [8]. Attenuation of host immunity can lead
to chronic reactivated infection mentioned above.
T. gondii can traverse the BBB and activate astrocytes as early as 10 days post-infection [9].
While tissue cysts are predominantly seen in neurons during chronic infection, they also occur
in microglia and astrocytes during earlier stages of infection [10]. Astrocytes execute several
immune functions that are involved in the intracerebral immune response to T. gondii. With
microglia and cerebral microvascular endothelial cells, astrocytes form the IFNγ effector cell
population that helps control tachyzoite replication in the brain. IFNγ-activated astrocytes sig-
nificantly inhibit the growth of tachyzoites in mice via an Immunity-Related GTPase (IRG)-
mediated mechanism [11,12] and by expressing pro-inflammatory agents [13–15].
To better understand host-parasite interactions, transcriptional profiling and proteomics
analyses have been carried out on T. gondii-infected versus uninfected cells. T. gondii infection
clearly modulates the host cell, resulting in dramatic changes in host gene expression [16–18]
and protein levels [19,20]. Data from Saeij et al. reveals that message levels for several lysine
acetyltransferases (KATs) and lysine deacetylases (KDACs) are significantly increased
(HDAC2 and HAT1) or decreased (SIRT5 and MYST4/MORF) in infected cells [17]. Modula-
tion of KATs and/or KDACs by intracellular pathogens could impact the host cell transcrip-
tome through histone (de)acetylation, thereby modifying the host cell milieu to favor
progression of the parasite’s life cycle.
The alteration of host KATs and KDACs is also likely to alter the acetylation status of non-
histone proteins as well; we and others have recently found that lysine acetylation is an abun-
dant post-translational modification (PTM) that occurs on thousands of proteins of diverse
function throughout multiple cellular compartments [21]. So-called “acetylomes” have now
been mapped for several organisms, including bacteria [22,23], plants [24,25], Saccharomyces
cerevisiae [26] Drosophila melanogaster [27], human cells [28,29], and the protozoan parasites
T. gondii and Plasmodium falciparum [30–32]. In this study, we present the first proteome-
wide analysis of lysine acetylation in cortical astrocytes. We also determined the acetylome of
T. gondii-infected astrocytes, which contained differences relative to the acetylated proteins
found in uninfected astrocytes. Our findings add a new layer of complexity to the mechanisms
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intracellular pathogens may employ to manipulate their host. These studies provide a founda-
tion for follow-up investigations aimed at determining the role of lysine acetylation on individ-
ual target proteins and how this impacts astrocytic function as well as T. gondii pathogenesis.
Materials and Methods
Astrocyte cultures
Astrocytes were cultured as previously described [33]. In brief, cortices from postnatal day 1–2
Sprague-Dawley rat pups were enzymatically digested and triturated. Cortical cells were then
resuspended in growth media (Dulbecco’s modified Eagle medium (DMEM) containing 5%
NuSerum, penicillin 10 units/mL, streptomycin (10μg/ml), L-glutamax (2mM) and B-27) at a
density of 2.5 million cells/mL, and resuspended onto 100 μg/ml poly-D-lysine (PDL) coated
10cm dishes. Cells were maintained in humidified incubators at 37°C under 5% CO2. Cells
were fed every 2–4 days and when the cultures became confluent (7–8 days in vitro (DIV)),
plates were shaken to remove oligodendrocytes and microglia. After a brief wash, trypsin was
used to passage the astrocytes, which were subsequently split onto PDL-coated 10cm dishes
(for proteomics or western blotting) or glass coverslips (for immunofluorescence). Similar to
previously published findings [33], cultures are negative for MAP-2 (neuronal marker), OX-42
(microglial marker), Olig-2 (oligodendrocyte marker) and GFAP positive (>98%, astrocyte
marker).
T. gondii culture and astrocyte infection
T. gondii were maintained in human foreskin fibroblasts (HFF; (ATCC CRL-1634)) using
DMEM supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen). RH strain
tachyzoites cultured in HFFs were then physically separated from host cells by passage through
a 23G syringe needle and purified from host cell debris using a 3.0 μm filter [34]. Following
centrifugation, parasites were resuspended in astrocyte growth medium (see above) and used
to infect astrocyte monolayers at a multiplicity of infection (MOI) of 10 for 10 h. Several inde-
pendent preparations had to be pooled in order to obtain 15 mg of protein lysate necessary to
generate the astrocyte acetylomes.
Immunoaffinity enrichment of lysine-acetylated peptides
Harvested astrocytes were washed in PBS and resuspended in urea lysis buffer (9.0 M urea,
20 mMHEPES pH 8.0, 2.5 mM sodium pyrophosphate, 1 mM β-glycerol phosphate, 1 mM so-
dium orthovanadate) freshly supplemented with 10 mM sodium butyrate, a lysine deacetylase
(KDAC) inhibitor. Sonicated lysates were centrifuged for 15 min at 4°C at 20,000 x g. Superna-
tants were collected and reduced with 4.5 mMDTT for 30 min at 55°C, followed by alkylation
with iodoacetimide and dilution with 20 mMHEPES, pH 8.0 to normalize protein concentra-
tion across all samples. After digestion with 10 μg/mL trypsin-TPCK in 1.0 mMHCl, peptide
lysates were acidified with 1% TFA and peptides were desalted over SEP PAK Classic C18 col-
umns (Waters). Peptides were eluted with 40% acetonitrile in 0.1% TFA, dried under vacuum,
and stored at-80°C.
Acetylated peptides were enriched using a pan-specific anti-acetyl-lysine antibody (CST
#9895, Cell Signaling Technology) bound to 50 mL packed protein A agarose beads (Roche).
Lyophilized peptides were resuspended in MOPS (morpholinepropane sulfonic acid) IAP buff-
er (50 mMMOPS (pH 7.2), 10 mM KH2PO4, 50 mM NaCl) and centrifuged for 5 min at
12,000 rpm. Supernatants were mixed with anti-acetyl-lysine beads for 2.5 h at 4°C and then
centrifuged for 30 s at 5,400 rpm at 4°C. Beads were washed in MOPS IAP buffer, then in
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water, prior to elution of the peptides with 0.15% TFA. In preparation for analysis, the peptides
were desalted over Empore C18 tips (Sigma) and eluted with 60% acetonitrile in 0.1% TFA.
LC-MS/MS analysis
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed at Cell Sig-
naling Technology (Danvers, MA). Peptides were loaded directly onto a 10 cm x 75 μm Pico-
Frit capillary column packed with Magic C18 AQ reversed-phase resin. The column was
developed with a 90-minute linear gradient of acetonitrile in 0.125% formic acid delivered at
280 nL/min. Tandem mass spectra were collected from duplicate samples in a data-dependent
manner with an LTQ Orbitrap VELOS mass spectrometer using a top 20 method, a dynamic
exclusion repeat count of 1 and a repeat duration of 35 s. MS/MS spectra were evaluated using
SEQUEST 3G and the SORCERER 2 platform from Sage-N Research (v4.0, Milpitas CA) [35].
Searches were performed against the most recent update of the NCBI Rattus norvegicus/Toxo-
plasma gondii combined database with mass accuracy of +/-50 ppm for precursor ions and 1
Da for product ions. Results were filtered with mass accuracy of +/− 5 ppm on precursor ions
and presence of an acetylated lysine. The mzXML, Dtas, and Out files associated with this
study are available upon request. Label-free quantification of individual acetylation sites was
performed as previously described, with the fold change for each identified acetylated lysine
was calculated by comparing changes in parent peptide ion intensities between uninfected and
infected samples [36,37].
Data analysis and bioinformatics
Acetylated proteins were classified according to gene ontology (GO) annotations by Uniprot
(http://www.uniprot.org) [38]. Cellular localization data were also extracted from Uniprot. The
secretome analysis was performed using Secretome 2.0 server (http://www.cbs.dtu.dk/services/
SecretomeP) [39]. Amino acid sequence motifs were analyzed using WebLogo 3.4 (http://
weblogo.threeplusone.com/create.cgi) [40].
Immunofluorescence assay
Immunofluorescence assays were performed as previously described [41]. Briefly, astrocyte
monolayers grown on coverslips were inoculated with RH strain tachyzoites. After removal of
culture medium, infected HFFs were fixed in 4% paraformaldehyde for 10 min and then were
permeabilized with 0.3% Triton X-100 for 10 min. For visualization of α-tubulin or α-tubulin
acetylated at K40, mouse monoclonal anti-α-tubulin antibody (clone DM1A, Sigma T6199)
and monoclonal anti-acetylated tubulin antibody (clone 6–11B-1, Sigma T7451) were applied
at 1:2,000 followed by goat anti-mouse Alexa Fluor 488 secondary antibody at 1:2,000 (Invitro-
gen, A-11001). Nuclei were visualized through co-staining with 40,6-diamidino-2-phenylindole
(DAPI).
Ethics statement
Astrocytes were obtained from postnatal rat pups (DIV1–2) using an approved protocol
(10354) from the Institutional Animal Care and Use Committee (IACUC) of the University of
Indiana School of Medicine (IUSM). The IUSM is accredited by the International Association
for Assessment and Accreditation of Laboratory Animal Care. Animals were anesthetized
using volatile anesthetics (halothane/isofluorane) and euthanized by decapitation.
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Results and Discussion
Proteome-wide analysis of lysine acetylated proteins in cortical
astrocytes
As the most abundant type of cell in the mammalian brain, astrocytes carry out a variety of es-
sential functions that include supporting synapse formation, synaptic transmission, and re-
sponding to neuronal stress. Astrocytes have been linked to neurodegenerative diseases, such
as Alzheimer’s, Parkinson’s, and Huntington’s, as well as amyotrophic lateral sclerosis [42,43].
Efforts to better understand the functions of astrocytes have included recent analyses of the
whole-cell proteome and secretome [44–49]. The most recent and comprehensive proteomics
study to date was performed using C8-D1A, a type-1 murine astrocyte cell line [50]. Using this
cell line, researchers identified 7,183 proteins in the whole-cell astrocyte proteome and 6,067
proteins in the secretome. To date, no one has examined the post-translational modifications
(PTMs) that may be decorating the proteome in transformed or dissociated astrocytes.
It has now been established for a wide variety of model organisms that thousands of proteins
are subject to lysine acetylation throughout cells; however, an acetylome has yet to be deter-
mined for any individual brain cell type to date. To address this knowledge gap, and to further
examine whether lysine acetylation is altered in response to infection, we performed proteome-
wide analyses of lysine acetylated proteins in cortical astrocytes obtained from rat using a strat-
egy outlined in Fig. 1. The significance of charting the astrocyte proteome is underscored by
previous studies suggesting that lysine deacetylase (KDAC) inhibitors, such as suberoylanilide
hydroxamic acid and valproic acid, show promise in treating some of the aforementioned
neurodegenerative diseases in which astrocytes may play a role [51–53]. We first describe the
results of the uninfected astrocytes, with the infected astrocyte acetylome discussed in the
following section.
Cortical astrocytes were cultured from postnatal day 1–3 Sprague-Dawley rat pups. Genera-
tion of whole cell lysates, affinity enrichment of peptides containing acetylated lysine residues,
Fig 1. Workflow for acetylome analysis of cortical astrocytes. Protein lysates generated from infected and uninfected cortical astrocytes were subjected
to proteolysis to generate a peptide suspension. Immunoaffinity purification with anti-acetyl-lysine antibody enriched for acetylated peptides (acetylation
mark is denoted by red dot). Identification of acetylated peptides was achieved with mass spectrometry.
doi:10.1371/journal.pone.0117966.g001
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and their identification by mass spectrometry were carried out essentially as described ([30];
see also Materials and Methods). Using this approach, we were able to detect lysine acetyl sites
on 516 non-redundant peptides across 304 astrocyte proteins at a false discovery rate (FDR)
for peptides of less than 5% (S1 Table). Highlighting the fidelity of our approach and source
sample, three marker proteins that distinguish astrocytes from other neuronal cells were de-
tected in our acetylome: fructose-bisphosphate aldolase C (lysine (K) acetylated at amino acid
residue 147 (K147)), nuclear factor 1 A-type, NFI-A (K276) and glial fibrillary acidic protein
(GFAP) (K258) [50,54,55].
For a global view of the acetylome, we categorized the acetylated astrocyte proteins into
functional groups based on gene ontology (S2 Table). The majority of the acetylated sites and
proteins cluster into groups including RNA processing/transcription, metabolism, chromatin
biology, and translation (Fig. 2A-B). As expected, histone proteins are heavily acetylated
(S3 Table). Acetylation and deacetylation of histones by histone acetyltransferases (HATs) or
Fig 2. Global features of the cortical astrocyte acetylome. Acetylated proteins (A) and residues (B) were sorted into functional groups based on GO
analyses. Lysine acetylation is most prevalent on proteins involved in RNA processing and transcription, metabolism, and chromatin biology. C. The 277
novel acetyl-lysine sites identified in our study are present on proteins that encompass a wide range of cellular functions. D. Proteins detected as lysine-
acetylated were grouped based on their respective cellular location.
doi:10.1371/journal.pone.0117966.g002
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histone deacetylases (HDACs), respectively, are well-established PTMs that modulate gene ex-
pression [56,57].
The first proteomic survey of lysine acetylation was performed in HeLa cells and identified
388 lysine acetylation sites across 195 proteins, which largely clustered into functional catego-
ries involving transcription, translation, and metabolism [58], which is comparable to our as-
trocyte acetylome. A subsequent study performed on human liver identified 1,047 proteins
containing lysine acetyl marks, preferentially on those involved in metabolism [29]. A cardiac
acetyl-lysine proteome was determined in guinea pigs, revealing that>60% of acetylated pro-
teins are mitochondrial and mainly involved in metabolism, as well as apoptosis and transcrip-
tion [59]. It is not surprising that different cell types would have variances in the type and
abundance of lysine acetylated proteins, but a striking commonality that emerges from these
collective acetylomes is the abundance of acetylation on metabolic proteins.
Of the 304 proteins we detected as being acetylated in astrocytes, 186 are novel, having
never been previously reported as acetylated in Rattus novergicus in Uniprot [38]; thus, our
data significantly expands the number of known acetylated lysine sites. The novel lysine acety-
lation marks we detected were found primarily on proteins associated with RNA processing
and transcription, metabolism, chromatin biology, and translation (Fig. 2C).
We examined the presence of acetylated proteins in different subcellular compartments.
Our data reveals that proteins subject to lysine acetylation in astrocytes are predominantly
found in the nucleus (38.5%), followed by the cytoplasm (28%) and mitochondria (20%). Elev-
en of the acetylated proteins (3.6% of the acetylome) are secreted from astrocytes (Fig. 2D).
One of the secreted proteins which we identified as acetylated is a complement protein in-
volved in innate immunity: C3, which is acetylated on K215 within the N-terminal beta chain
region. Complement C3 has not previously been reported to be acetylated, so it is unclear what
the function of this acetylation site may be. It is possible that acetylation of complement C3
could alter folding of the protein and affect secretion and/or cleavage of C3 by C3 convertase,
thus regulating the downstream complement cascade. This is particularly intriguing consider-
ing our finding that this acetyl mark is increased 3.3-fold upon T. gondii infection (see below),
lending support to the idea that acetylation of K215 on C3 may modulate complement func-
tion. Treatment with the lysine deacetylase (KDAC) inhibitors sodium butyrate and Trichosta-
tin A has been shown to enhance complement C3 expression and secretion, through increased
histone acetylation [60], but the direct action of KDACs on complement C3 itself was not
considered.
Transmembrane glycoprotein NMB precursor (Gpnmb) was another secreted protein on
which a novel acetylation site was identified, K170. Also known as osteoclavin in rats, this high-
ly glycosylated protein is anchored in the plasma membrane and has been shown to regulate
cellular differentiation, specifically the development of osteoblasts in bone [61]. Gpnmb was
also found to be upregulated in both neurons and astrocytes after brain ischaemic injury in rats
and overexpression of Gpnmb was protective against ischaemic injury [62], indicating a role
for Gpnmb in neuroprotection. Acetylation of Gpnmb may be involved in the regulation of
these neural repair processes, through controlling Gpnmb secretion or glycosylation.
As mentioned above, histone proteins are known to be heavily acetylated and this is no ex-
ception in astrocytes (S3 Table). Unexpectedly, we found novel histone acetylation sites on
some astrocyte histones. For example, linker histone H1C is acetylated at K17, K75, and K84,
in addition to the previously detected K46, K90, and K106 (http://www.phosphosite.org/
proteinAction.do?id=3849&showAllSites=true) [63]. The most abundant acetylated non-his-
tone protein in cultured cortical rat astrocytes is α-tubulin, which we detected as acetylated at
K40. K40 acetylation is widespread among eukaryotes and its role in the cell remains a topic of
intense investigation. Acetylated tubulin is a feature of long-lived, stable microtubules [64] and
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may interplay with additional PTMs to form a “tubulin code” that provides microtubules flexi-
bility to execute a wide variety of cellular functions [65]. We performed immunofluorescent
analysis using an antibody specific against the acetylated K40 residue of tubulin, which con-
firms that acetylated microtubules are abundant in cortical astrocytes and localized uniformly
throughout the cell (Fig. 3).
A KEGG pathway analysis using DAVID (Database for Annotation, Visualization and Inte-
grated Discovery; http://david.abcc.ncifcrf.gov/home.jsp) [66,67] of the astrocyte acetylome
clustered 123 of the 304 acetylated proteins as proteins linked to neurological disorders, such
as Huntington’s disease (18 proteins), Parkinson’s disease (15 proteins), and Alzheimer’s dis-
ease (12 proteins) (Table 1 and S4 Table). Acetylated proteins are also associated with canoni-
cal metabolic pathways that have been shown to be specifically enriched in astrocytes
compared to neurons and oligodendrocytes [68], including the citrate cycle, fatty acid metabo-
lism, and valine, leucine, and isoleucine degradation (S4 Table).
We also assessed if the amino acids flanking the targeted acetyl-lysine exhibits bias towards
a certain motif and if there is significant enrichment or absence of specific amino acids with re-
spect to the general amino acid composition of the entire Rattus norvegicus proteome. For
these analyses, we generated WebLogo sequence motifs [40] and IceLogo heat maps [69]. As
previously reported for multiple cell types, we found that lysine acetylation of astrocyte pro-
teins also generally occurs in lysine-rich regions, with a significant enrichment for glycine and
alanine at positions-1, -2, and-3 and positions +1, +2, and +5 for alanine only, as shown in
Fig. 4A [27,28]. The heat map also shows an absence of serine, proline, and histidine at position
+1, and a general lack of leucine in the vicinity of the acetylation site. However, the preponder-
ance of histone proteins in acetylome datasets likely biases the global motif analysis; searching
for only the acetylated proteins in mitochondria reveals a striking deviance from other acetyla-
tion sites (Fig. 4B). In the acetylated proteins in astrocyte mitochondria, there is a modest en-
richment for glutamate (E) at the-1 position, which has been observed before in multiple
studies [70]. Analysis of the histone proteins alone revealed a high conservation of the GK
Fig 3. Localization of acetylated tubulin in astrocytes. The subcellular localization of α-tubulin acetylated at K40 (upper panels) and total α-tubulin (lower
panels) through immunofluorescence of isolated cortical astrocytes (green). DAPI staining to highlight nuclei is indicated in blue. Scale bar = 20 μm.
doi:10.1371/journal.pone.0117966.g003
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Table 1. Proteins involved in neurological disorders that are acetylated in murine astrocytes.
Neurological disorder Accession number Protein name
Huntington’s Disease Q9Z2L0 voltage-dependent anion-selective channel protein 1
P10719 ATP synthase subunit beta, mitochondrial precursor
P35434 ATP synthase subunit delta, mitochondrial precursor
B2RYS2 cytochrome b-c1 complex subunit 7
Q4QQW4 histone deacetylase 1
P81155 voltage-dependent anion-selective channel protein 2
P19511 ATP synthase subunit b, mitochondrial precursor
P29418 ATP synthase subunit epsilon, mitochondrial
P15999 ATP synthase subunit alpha, mitochondrial precursor
P31399 ATP synthase subunit d, mitochondrial
Q09073 ADP/ATP translocase 2
Q920L2 succinate dehydrogenase [ubiquinone] ﬂavoprotein subunit, mitochondrial precursor
Q6JHU9 CREB-binding protein
Q05962 ADP/ATP translocase 1
Q5M9I5 cytochrome b-c1 complex subunit 6, mitochondrial
P07895 superoxide dismutase [Mn], mitochondrial precursor
Q9R1Z0 voltage-dependent anion-selective channel protein 3
Q06647 ATP synthase subunit O, mitochondrial precursor
Parkinson’s Disease Q9Z2L0 voltage-dependent anion-selective channel protein 1
P10719 ATP synthase subunit beta, mitochondrial precursor
P35434 ATP synthase subunit delta, mitochondrial precursor
B2RYS2 cytochrome b-c1 complex subunit 7
P81155 voltage-dependent anion-selective channel protein 2
P19511 ATP synthase subunit b, mitochondrial precursor
P29418 ATP synthase subunit epsilon, mitochondrial
P15999 ATP synthase subunit alpha, mitochondrial precursor
P31399 ATP synthase subunit d, mitochondrial
Q09073 ADP/ATP translocase 2
Q920L2 succinate dehydrogenase [ubiquinone] ﬂavoprotein subunit, mitochondrial precursor
Q05962 ADP/ATP translocase 1
Q5M9I5 cytochrome b-c1 complex subunit 6, mitochondrial
Q9R1Z0 voltage-dependent anion-selective channel protein 3
Q06647 ATP synthase subunit O, mitochondrial precursor
Alzheimer’s Disease P19511 ATP synthase subunit b, mitochondrial precursor
P15999 ATP synthase subunit alpha, mitochondrial precursor
P29418 ATP synthase subunit epsilon, mitochondrial
P31399 ATP synthase subunit d, mitochondrial
P10719 ATP synthase subunit beta, mitochondrial precursor
P35434 ATP synthase subunit delta, mitochondrial precursor
P62161 calmodulin
B2RYS2 cytochrome b-c1 complex subunit 7
Q920L2 succinate dehydrogenase [ubiquinone] ﬂavoprotein subunit, mitochondrial precursor
P04797 glyceraldehyde-3-phosphate dehydrogenase
Q5M9I5 cytochrome b-c1 complex subunit 6, mitochondrial
Q06647 ATP synthase subunit O, mitochondrial precursor
doi:10.1371/journal.pone.0117966.t001
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motif, with additional lysines at the + and—4 positions, consistent with acetylated histones in
other species and cell types [28,58]. Our data lends support to the idea that different motifs are
targeted by distinct KATs residing in that particular cellular compartment [70].
Differences in lysine acetylation in astrocytes infected with T. gondii
The results above establish that many other proteins in addition to histones are subject to lysine
acetylated in astrocytes. We also addressed how the acetylome in cortical astrocytes is impacted
by T. gondii infection. In parallel studies, we performed an acetylome on astrocytes that were in-
fected with RH strain T. gondii tachyzoites for 10 hours, at which point vacuoles contain 2–4 par-
asites. Compared to the uninfected astrocytes, 58 proteins were differentially acetylated when
infected with T. gondii. Table 2 lists the 34 proteins that exhibit at least a 2-fold increase in lysine
acetylation; 9 of these proteins contain 10 novel acetylated lysines that have yet to be reported.
Notably, several of the acetylated proteins in the infected astrocytes are transcription factors
and KATs themselves, which may be involved with the profound changes in gene expression pro-
grams previously observed in other T. gondii-infected cells. Consistent with the up-regulation of
Fig 4. Analysis of acetylated lysine sites. A. Heat map of amino acid composition of acetylation sites in Rattus norvegicus astrocytes, displaying amino
acids that are significantly enriched (green) or absent (red) relative to the general amino acid composition of the Rattus norvegicus proteome. B. Sequence
motifs of astrocyte acetylation sites +/-7 amino acids from the targeted lysine residue. Motifs were compiled using all acetylated peptides or only those found
in histones, non-histone proteins, or mitochondrial proteins.
doi:10.1371/journal.pone.0117966.g004
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host cell genes upon T. gondii invasion, hyperacetylation of canonical histones is observed, partic-
ularly on H3.3, which shows a remarkable 600-fold increase in lysine acetylation (Table 2). Such
a large effect on histone acetylation suggests that modulations in host cell gene expression are
largely driven at the epigenetic level.
Table 2. Proteins showing 2-fold increase in lysine acetylation in T. gondii-infected astrocytes.
Functional Group Accession
number
Protein name Normalized
Fold-change
T. gondii:control
Chromatin Biology P62804 histone H4 2.2
XP_001054684 histone H4 replacement-like 2.4
P84245 histone H3.3B-like 4.4
P0C0S7 histone H2A.Z 11.5
Q6LED0 histone H3.3 665.7
Differentiation F1LRS2 dedicator of cytokinesis 7 3.3
Immunity P01026 complement C3 3.3
Metabolism P97519 hydroxymethylglutaryl-CoA lyase, mitochondrial
precursor
2.1
P04636 malate dehydrogenase, mitochondrial precursor 2.1
P17764 acetyl-CoA acetyltransferase, mitochondrial precursor 2.1
P12785 fatty acid synthase 2.3
P29411 GTP:AMP phosphotransferase, mitochondrial 2.4
Q811I0 ATP synthase mitochondrial F1 complex assembly
factor 1
3.4
P15999 ATP synthase subunit alpha, mitochondrial precursor 4.2
Miscellaneous P07895 superoxide dismutase [Mn], mitochondrial precursor 2.1
P48679 prelamin-A/C isoform C2 2.7
P07895 superoxide dismutase [Mn], mitochondrial precursor 5.4
Q6P7C7 transmembrane glycoprotein NMB precursor 136
RNA processing & transcription B0BNB4 mediator of RNA polymerase II transcription subunit 6 2.2
Q66H19 serum response factor-binding protein 1 2.2
Q6IMY8 heterogeneous nuclear ribonucleoprotein U 3
P09416 myc proto-oncogene protein (c-Myc) 3
P0C1G9 transcription factor SOX-11 3.5
Q5TKR9 histone acetyltransferase MYST3 5.2
Q6JHU9 CREB-binding protein (CBP) 6.6
Q99MK2 histone acetyltransferase KAT5/TIP60 6.9
Stress response, chaperones, protein
degradation
P26772 10 kDa heat shock protein, mitochondrial 2
P14659 heat shock-related 70 kDa protein 2 2.3
Translation & ribosomal proteins Q3T1J1 eukaryotic translation initiation factor 5A-1 2.8
P18445 60S ribosomal protein L27a 4.5
Transport Q75Q39 mitochondrial import receptor subunit TOM70 2.1
P61972 nuclear transport factor 2 2.9
P02770 serum albumin precursor 6.3
Unknown Q5RKH0 putative oxidoreductase GLYR1 2
doi:10.1371/journal.pone.0117966.t002
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The greatest increase in acetylation in response to T. gondii infection on a non-histone pro-
tein occurs on K170 of GPNMB/osteoactivin, a type I transmembrane glycoprotein nonmeta-
static melanoma B (136-fold increase, Table 2). GPNMB plays multiple roles, including bone
regeneration, tumor growth regulation, and T-cell inactivation [71–73]. In astrocytes, GPNMB
is secreted as a neuroprotective factor [62,74]. As GPNMB is also important for tissue repair
[75], this protein may help manage the damage done by the parasite. The role of acetylation on
GPNMB is unknown, and there has been no previous link between this protein and T.
gondii infection.
Increased acetylation in select proteins during infection may be due in part to acetylation of
KATs like CBP and TIP60 themselves, which display a 6.6- and 6.9-fold increase, respectively
(Table 2). K327 acetylation, for example, has been linked to maximizing TIP60 enzyme activity
[76]. TIP60 has also been shown to interact with and acetylate c-Myc, dramatically enhancing
the stability of c-Myc protein [77]. It is tempting to speculate that T. gondii infection modulates
these KAT enzymes, which then leads to hyperacetylation of their corresponding substrates.
Two dozen astrocyte proteins exhibited 2-fold less acetylated lysine levels in the acetylome
from T. gondii-infected astrocytes (Table 3), and 28 of the acetylated lysines across these 24
proteins have never been reported in Uniprot. Nearly 30% of the decreased acetylation appears
on variant histones, suggesting that T. gondii infection of astrocytes is a large driver of changes
Table 3. Proteins showing 2-fold decrease in lysine acetylation in T. gondii-infected astrocytes.
Functional group Accession
number
Protein name Normalized Fold-
change
T. gondii:control
Cell cycle B2RYQ5 enhancer of rudimentary homolog -2.3
Chromatin Biology D3ZWM5 histone cluster 1, H2bd-like -2.6
Q9Z2Q9 histone H2B -2.6
Q63945 protein SET -2.7
D3ZLY9 histone cluster 1, H2bp -3.1
G3V8B3 histone cluster 1, H2bm -3.5
P62804 histone cluster 1, H4m -3.7
M0RCB8 histone H3.3B-like -6
D3ZNZ9 histone cluster 3, H2ba -10.1
Cytoskeleton P68370 tubulin alpha-1A chain -2.3
Differentiation P62161 calmodulin -2.4
Metabolism Q9EQS0 transaldolase -2.3
P16617 phosphoglycerate kinase 1 -3
P56574 isocitrate dehydrogenase [NADP], mitochondrial
precursor
-10.2
Miscellaneous P10111 peptidyl-prolyl cis-trans isomerase A -2.2
RNA processing & transcription A7VJC4 heterogeneous nuclear ribonucleoproteins A2/B1 -2
B0BNB4 chromatin modiﬁcation-related protein MEAF6 -2.1
Q4V898 heterogeneous nuclear ribonucleoprotein G -2.3
A1L130 inhibitor of growth protein 4 -2.4
D4A411 peregrin -11.3
Stress response, chaperones, protein
degradation
Q91XW0 heat shock protein HSP90-alpha -19.2
Translation & ribosomal proteins Q68FR6 elongation factor 1-gamma -2.2
Transport P02693 fatty acid-binding protein, intestinal -2.1
Q05962 ADP/ATP translocase 1 -7
doi:10.1371/journal.pone.0117966.t003
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in host gene expression. Previous studies have shown that T. gondii infection results in de-
creased acetylation of core histones H3 and H4 located at the promoters of IFNγ-regulated
genes [78]. However, no studies have examined the roles of histone variants in host cells in-
fected with T. gondii. Our results suggest that the rewiring of host cell gene expression in re-
sponse to infection is highly sophisticated and may involve an opposing interplay of
acetylation on canonical versus variant histones.
The most dramatic reduction of lysine acetylation was observed for K408 of the heat shock
protein Hsp90α, exhibiting a 19.2-fold decrease in the acetylome of infected astrocytes
(Table 3). Hsp90α is an essential molecular chaperone that activates multiple client proteins
typically in response to cellular stress [79]. Activation of Hsp90α and interactions with its client
proteins and co-chaperones are mediated by several PTMs including lysine acetylation [80].
The acetylation of K408 has not been reported to date, but it was detected as ubiquitylated in
mice and humans [81,82], making it possible that acetylation here prevents Hsp90α degrada-
tion. The dramatic reduction in deacetylation of K408 suggests that Hsp90αmay be suppressed
in response to T. gondii infection.
Another protein with greatly reduced acetylation (<10-fold) in the infected astrocyte acety-
lome is isocitrate dehydrogenase (IDH2), at K180. As a supplier of NADPH, IDH2 is a critical
component of the mitochondrial antioxidant pathway [83], and is necessary for the regenera-
tion of reduced glutathione (GSH), the major antioxidant responsible for preventing ROS dam-
age [84]. IDH2 acetylation at K143 results in a 44-fold loss in activity; deacetylation by SIRT3
restores IDH2 activity and protects cells from oxidative stress [85]. It is possible that T. gondii
mediates a deacetylation of IDH2 to protect its host cell from oxidative or other stresses associ-
ated with managing infection, but further studies are required to determine the role this lysine
plays in IDH2 function in both infected and uninfected astrocytes.
Conclusions
Recent studies have implicated important roles for lysine acetylation in other cell types during
viral infection that involve interference with host cell KATs [86], hijacking of host cell acety-
lome machinery or acetylation of viral proteins [87–91], and other changes in lysine acetylation
during infection or in response to viral pathogens [92,93]. Intracellular bacteria also effect host
cell lysine acetylation. For example, Salmonella enterica appear to exploit the host TIP60 KAT
activity to promote efficient replication inside host cells [94]. Additionally, Salmonella typhi-
murium infection increases p53 acetylation in intestinal epithelial cells [95]. Our study lends
support to the idea that intracellular pathogens modulate host cell proteomes and PTMs such
as lysine acetylation. Previously, it has also been shown that host cell proteins can be differen-
tially phosphorylated in response to T. gondii infection [19].
It is important to note that some of the changes in acetylation detected in the infected astro-
cytes could potentially be reflective of changes in the abundance of that protein induced by the
infection. Future studies are required to elucidate the biological consequences of the changes
we detected in the astrocyte acetylome upon infection with T. gondii, as alterations in lysine
acetylation status could affect protein localization, function, stability, or interactions [96].
T. gondii secretes numerous proteins that alter host cell protein phosphorylation [97–99].
T. gondii possesses several KATs and KDACs, but there is no evidence that these are secreted.
A more likely mechanism is that T. gondii effector proteins modulate host KATs and KDACs
activities that lead to altered acetylation patterns. Our datasets provide a wealth of new infor-
mation, including 186 novel lysine acetylation sites to add to the cellular inventory of PTMs.
These data serve as valuable resources to generate hypotheses about astrocyte physiology and
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to interrogate how the changes in host cell lysine acetylation may contribute to the effectiveness
of T. gondii infection.
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